Mitochondrial replacement therapy in reproductive medicine

Trends in Molecular Medicine

Volumn 21, Issue 2, 2015, Pages 68-76

  Wolf, Don P ^a,b   Mitalipov, Nargiz ^a,b   Mitalipov, Shoukhrat ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Female infertility; Mitochondria; Mitochondrial DNA; Mitochondrial replacement therapy

Indexed keywords

MITOCHONDRIAL DNA;

EXPERIMENTAL THERAPY; GERM LINE GENE THERAPY; HUMAN; INFERTILITY; MEDICAL ETHICS; MITOCHONDRIAL REPLACEMENT THERAPY; MITOCHONDRION; MOLECULAR PATHOLOGY; NONHUMAN; OOCYTE; POLAR BODY; PROCEDURES CONCERNING CELLS; PRONUCLEUS; REPRODUCTION; REVIEW; SOMATIC GENE THERAPY; SPINDLE CELL; ANIMAL; BIOLOGICAL THERAPY; FEMALE; GENETICS; METABOLISM; MITOCHONDRIAL DISEASES; PREGNANCY; ZYGOTE;

MUS; PRIMATES;

ANIMALS; BIOLOGICAL THERAPY; FEMALE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; PREGNANCY; REPRODUCTIVE MEDICINE; ZYGOTE;

EID: 84922947421     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.12.001     Document Type: Review

References (51)

1. Hamilton G. The micromanagers. New Sci. 2014, 223:42-45.
2. Wallace D.C., Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb. Perspect. Med. 2013, 3:a021220.
3. Chinnery P.F., Hudson G. Mitochondrial genetics. Br. Med. Bull. 2013, 106:135-159.
4. Wallace D.C., et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430.
5. Zeviani M., et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988, 38:1339-1346.
6. Elliott H.R., et al. Pathogenic mitochondrial DNA mutations are common in the general population. Am. J. Hum. Genet. 2008, 83:254-260.
7. Mitalipov S., et al. Limitations of preimplantation genetic diagnosis for mitochondrial DNA diseases. Cell Rep. 2014, 7:935-937.
8. McGrath J., Solter D. Nuclear transplantation in the mouse embryo by microsurgery and cell fusion. Science 1983, 220:1300-1302.
9. Sato A., et al. Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16765-16770.
10. Meirelles F.V., Smith L.C. Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embryonic karyoplast transplantation. Genetics 1997, 145:445-451.
11. Meirelles F.V., Smith L.C. Mitochondrial genotype segregation during preimplantation development in mouse heteroplasmic embryos. Genetics 1998, 148:877-883.
12. Wang T., et al. Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell 2014, 157:1591-1604.
13. Sathananthan A.H., Trounson A.O. Mitochondrial morphology during preimplantational human embryogenesis. Hum. Reprod. 2000, 15(Suppl. 2):148-159.
14. Van Blerkom J., et al. Differential mitochondrial distribution in human pronuclear embryos leads to disproportionate inheritance between blastomeres: relationship to microtubular organization, ATP content and competence. Hum. Reprod. 2000, 15:2621-2633.
15. Samuels D.C., et al. Preventing the transmission of pathogenic mitochondrial DNA mutations: Can we achieve long-term benefits from germ-line gene transfer?. Hum. Reprod. 2013, 28:554-559.
16. Craven L., et al. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 2010, 465:82-85.
17. Tachibana M., et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009, 461:367-372.
18. Lee H.S., et al. Rapid mitochondrial DNA segregation in primate preimplantation embryos precedes somatic and germline bottleneck. Cell Rep. 2012, 1:506-515.
19. Tachibana M., et al. Chromosome transfer in mature oocytes. Nat. Protoc. 2010, 5:1138-1147.
20. Tachibana M., et al. Chromosome transfer in mature oocytes. Fertil. Steril. 2012, 97:e16.
21. Paull D., et al. Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature 2013, 493:632-637.
22. Tachibana M., et al. Towards germline gene therapy of inherited mitochondrial diseases. Nature 2013, 493:627-631.
23. Wakayama T., Yanagimachi R. The first polar body can be used for the production of normal offspring in mice. Biol. Reprod. 1998, 59:100-104.
24. Wakayama T., et al. Participation of the female pronucleus derived from the second polar body in full embryonic development of mice. J. Reprod. Fertil. 1997, 110:263-266.
25. Daughtry B., Mitalipov S. Concise review: parthenote stem cells for regenerative medicine: genetic, epigenetic, and developmental features. Stem Cells Transl. Med. 2014, 3:290-298.
26. Minami N., et al. Zygotic gene activation and maternal factors in mammals. J. Reprod. Dev. 2007, 53:707-715.
27. Schultz G.A., Heyner S. Gene expression in pre-implantation mammalian embryos. Mutat. Res. 1992, 296:17-31.
28. Tang F., et al. Maternal microRNAs are essential for mouse zygotic development. Genes Dev. 2007, 21:644-648.
29. Keefe D.L., et al. Mitochondrial deoxyribonucleic acid deletions in oocytes and reproductive aging in women. Fertil. Steril. 1995, 64:577-583.
30. Wilding M., et al. Mitochondrial aggregation patterns and activity in human oocytes and preimplantation embryos. Hum. Reprod. 2001, 16:909-917.
31. Van Blerkom J., et al. ATP content of human oocytes and developmental potential and outcome after in-vitro fertilization and embryo transfer. Hum. Reprod. 1995, 10:415-424.
32. Van Blerkom J. Mitochondrial function in the human oocyte and embryo and their role in developmental competence. Mitochondrion 2011, 11:797-813.
33. Tsai H.D., et al. Mitochondria DNA deletion and copy numbers of cumulus cells associated with in vitro fertilization outcomes. J. Reprod. Med. 2010, 55:491-497.
34. Schon E.A., et al. Chromosomal non-disjunction in human oocytes: is there a mitochondrial connection?. Hum. Reprod. 2000, Suppl. 2:160-172.
35. Eichenlaub-Ritter U., et al. Age related changes in mitochondrial function and new approaches to study redox regulation in mammalian oocytes in response to age or maturation conditions. Mitochondrion 2011, 5:783-796.
36. Cohen J., et al. Ooplasmic transfer in mature human oocytes. Mol. Hum. Reprod. 1998, 4:269-280.
37. Bellieni C.V. Neonatal risks from in vitro fertilization and delayed motherhood. World J. Clin. Pediatr. 2012, 1:34-36.
38. Braveman F.R. Pregnancy in patients of advanced maternal age. Anesthesiol. Clin. 2006, 24:637-646.
39. Habbema J.D., et al. The effect of in vitro fertilization on birth rates in western countries. Hum. Reprod. 2009, 24:1414-1419.
40. Robertson J.A. Reconstituting eggs: the ethics of cytoplasm donation. Fertil. Steril. 1999, 71:219-221.
41. Chinnery P.F., et al. The challenges of mitochondrial replacement. PLoS Genet. 2014, 10:e1004315.
42. Reinhardt K., et al. Medicine. Mitochondrial replacement, evolution, and the clinic. Science 2013, 341:1345-1346.
43. Nagao Y., et al. Decreased physical performance of congenic mice with mismatch between the nuclear and the mitochondrial genome. Genes Genet. Syst. 1998, 73:21-27.
44. Roubertoux P.L., et al. Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nat. Genet. 2003, 35:65-69.
45. Jenuth J.P., et al. Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat. Genet. 1996, 14:146-151.
46. Rienzi L., et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum. Reprod. 2012, 27:1606-1612.
47. Connor S. Medical dilemma of 'three-parent babies': fertility clinic investigates health of teenagers it helped to be conceived through controversial IVF technique. Independent 2014, 25 August.
48. Genovese P., et al. Targeted genome editing in human repopulating haematopoietic stem cells. Nature 2014, 510:235-240.
49. Yusa K., et al. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011, 478:391-394.
50. Suzuki K., et al. Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. Cell Stem Cell 2014, 15:31-36.
51. Schwank G., et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 2013, 13:653-658.